STRS OHIO - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 165 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
STRS OHIO ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$250
-34.6%
58,0000.0%0.00%
-50.0%
Q2 2023$382
-64.9%
58,000
-63.9%
0.00%0.0%
Q1 2023$1,089
+175.7%
160,500
+200.0%
0.00%0.0%
Q4 2022$395
-99.9%
53,500
+17.3%
0.00%0.0%
Q3 2022$450,000
-9.5%
45,6000.0%0.00%0.0%
Q2 2022$497,000
+2.3%
45,600
+6.0%
0.00%0.0%
Q1 2022$486,000
+71.7%
43,000
+137.6%
0.00%
+100.0%
Q4 2021$283,000
-12.1%
18,100
-3.7%
0.00%0.0%
Q3 2021$322,000
-20.3%
18,8000.0%0.00%0.0%
Q2 2021$404,000
+58.4%
18,800
+10.6%
0.00%0.0%
Q1 2021$255,000
-38.1%
17,000
-45.9%
0.00%
-50.0%
Q4 2020$412,000
-32.8%
31,400
-50.6%
0.00%
-33.3%
Q3 2020$613,000
+2.9%
63,500
+21.9%
0.00%0.0%
Q2 2020$596,000
-0.8%
52,100
-10.3%
0.00%0.0%
Q1 2020$601,000
-20.5%
58,100
+26.0%
0.00%0.0%
Q4 2019$756,000
-45.5%
46,100
-55.8%
0.00%0.0%
Q3 2019$1,386,000
+93.8%
104,400
+105.5%
0.00%0.0%
Q2 2019$715,000
-8.6%
50,800
+19.5%
0.00%
-25.0%
Q1 2019$782,000
-9.5%
42,500
+28.4%
0.00%0.0%
Q4 2018$864,000
-8.1%
33,100
-19.3%
0.00%0.0%
Q3 2018$940,000
+4.0%
41,000
-13.7%
0.00%0.0%
Q2 2018$904,000
+24.0%
47,500
+9.7%
0.00%
+33.3%
Q1 2018$729,000
-14.6%
43,300
-23.0%
0.00%
-25.0%
Q4 2017$854,000
+8.2%
56,200
+27.4%
0.00%
+33.3%
Q3 2017$789,000
+0.9%
44,100
-8.1%
0.00%0.0%
Q2 2017$782,000
+12.7%
48,000
-3.2%
0.00%0.0%
Q1 2017$694,000
-8.2%
49,600
+4.6%
0.00%0.0%
Q4 2016$756,000
+2.9%
47,400
+7.2%
0.00%0.0%
Q3 2016$735,000
+6.5%
44,200
-28.4%
0.00%0.0%
Q2 2016$690,000
+7.8%
61,700
-19.5%
0.00%0.0%
Q1 2016$640,00076,6270.00%
Q1 2015$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q4 2014$861,000
-35.7%
60,100
-53.4%
0.00%
+33.3%
Q3 2014$1,340,000
+249.9%
129,000
+444.3%
0.00%
+50.0%
Q2 2014$383,000
+6.7%
23,700
+7.2%
0.00%0.0%
Q1 2014$359,000
+66.2%
22,100
+27.0%
0.00%
+100.0%
Q4 2013$216,000
+1.4%
17,400
-10.3%
0.00%0.0%
Q3 2013$213,000
+195.8%
19,400
+118.0%
0.00%
Q2 2013$72,0008,9000.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Palo Alto Investors LP 4,525,476$74,263,0004.09%
ARMISTICE CAPITAL, LLC 2,828,000$46,407,0002.68%
Birchview Capital, LP 80,000$1,313,0000.95%
GLOBEFLEX CAPITAL L P 145,426$2,386,0000.45%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 231,733$3,803,0000.36%
361 CAPITAL LLC 77,630$1,274,0000.35%
CADENCE CAPITAL MANAGEMENT LLC 152,428$2,501,0000.27%
BOOTHBAY FUND MANAGEMENT, LLC 148,000$2,429,0000.21%
EMERALD ADVISERS, LLC 258,497$4,242,0000.18%
EMERALD MUTUAL FUND ADVISERS TRUST 251,730$4,131,0000.17%
View complete list of VANDA PHARMACEUTICALS INC shareholders